Stay updated on MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial
Sign up to get notified when there's something new on the MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial page.

Latest updates to the MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial page
- Check6 days agoChange DetectedNew entries were added to the record history, reflecting recent updates with additional version dates. The core study details and statuses appear unchanged.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check34 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference9%

- Check42 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

- Check56 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.5%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.5%

- Check70 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity and relevance of the page's content regarding study statuses and locations.SummaryDifference52%

Stay in the know with updates to MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial page.